跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salmeflo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salmeflo
Approved
STANDARD
Salmeflo
Lloyd Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
09d05ad5136db300
Company
Lloyd Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
09d05ad5136db300
Drug Approval Philippines Name
Salmeflo
Product Name
Salmeflo
Registration Number
DRP-1266
Brand Name
Salmeflo
Generic Name
Salmeterol Xinafoate + Fluticasone Propionate
Dosage Form
Metered Dose Inhaler
Dosage Strength
25 mcg / 125 mcg per Actuation
Manufacturer
Lloyd Laboratories Pvt. Ltd.
Importer
Innogen Pharmaceuticals, Inc.
Distributor
Innogen Pharmaceuticals, Inc.
Issuance Date
29 April 2023
Expiry Date
18 April 2028
Pharmacologic Category
Beta-2-Adrenoceptor Agonist/Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
09d05ad5136db300
Type
Standard
Back to Philippines FDA Approvals